Roche Holding is a pioneer in Healthcare Company with headquarters in Basel, Switzerland. Roche is the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in Roche Company products pipeline are biopharmaceuticals, enabling them to deliver better-targeted therapies. They are specialized in Oncology, Neuroscience, Infectious Diseases, Immunology, Cardiovascular and Metabolism, Opthamology and Respiratory branches Medicines.
Novartis is Switzerland based Multi-National Healthcare and Pharmaceutical company. Novartis Company focus on patented medicines, generic medicines and eye care – segments where they have the innovation power and global scale necessary to compete effectively. At the same time, Novartis is expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high- quality medicines and healthcare. They have over 104,323 employees worldwide as on 2021.
Novo Nordisk is Denmark based Multinational Pharmaceutical Company. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Headquartered in Denmark, Novo Nordisk employs approximately 45,971 employees in 79 countries as on 2021 and markets its products in more than 170 countries.
For year ending December-2021, Annual Revenue was 140,800 Million DKK and Net Income was 47,757 Million DKK.
ASTRAZENECA is UK Based Pharmaceutical and Bio-Technology Company. In the fight against COVID-19,Astrazeneca is one among World Top 5 Companies which is in advanced phase of Covid-19 testing in collaboration with the University of Oxford and are launching Phase III trials. Headquarters is in UK.
AstraZeneca has annual revenue was 37,417 million USD for year ending Dec-2021 when compared to with 26,617 million USD as on 2020.
Facts About Company
Astrazeneca company acquired Alexion Pharmaceuticals for 39 Billion USD in 2020.
As on 2021, Astrazeneca has 83,100 employees and out of that
GLAXOSMITHKLINE is UK based multi-national Pharmaceuticals business and it has a broad portfolio of innovative and established medicines. GSK currently focus on developing new medicines in respiratory, HIV, oncology and immuno-inflammation; with an R&D approach focused on science related to the immune system, use of genetics and advanced technologies. Headquarters is in UK.
In 2021 GSK delivered 1.7 billion medicines, over 767 million vaccines* and 3.7 billion consumer healthcare products.